Pantheon Vision

Pantheon Vision is an early-stage biotechnology company dedicated to developing bioengineered corneal implants to improve corneal surgeries and reduce reliance on donor tissue, thereby addressing corneal blindness in both emerging and developed markets. After its establishment, the company received initial funding from KeraLink International to fulfill its mission of eliminating corneal blindness globally, with a primary focus on low- and middle-income countries.